Saphenous vein grafts (SVGs) remain the most frequently used conduits in coronary artery
bypass graft surgery (CABG). Despite advances in surgical techniques and …

Importance The role of ticagrelor with or without aspirin after coronary artery bypass graft
surgery remains unclear. Objective To compare the risks of vein graft failure and bleeding …

BACKGROUND: Graft patency is the postulated mechanism for the benefits of coronary
artery bypass grafting (CABG). However, systematic graft imaging assessment after CABG is …

Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …

Objective To assess the effect of different antiplatelet strategies on clinical outcomes after
coronary artery bypass grafting. Design Five year follow-up of randomised Different …

Antiplatelet therapy plays a crucial role in a number of cardiovascular disorders. We
currently have a range of antiplatelet agents in our armamentarium. In this review, we aim to …

Coronary artery bypass grafting is the most commonly performed cardiac surgical
procedure. Conduit selection is crucial to achieving early optimal outcomes, with graft …

Background Antiplatelet therapy prevents saphenous vein graft (SVG) occlusion and
improves outcomes after coronary artery bypass graft surgery (CABG). However, the optimal …

Ticagrelor is a platelet P2Y12 receptor inhibitor approved for use in patients with acute
coronary syndromes, coronary artery disease, and low‐moderate risk acute ischemic stroke …

Objectives Relative rates of early graft failure and conduit selection in coronary artery
bypass grafting (CABG) surgery remain controversial. Therefore, we sought to determine the …